Humasis Signs Contract to Supply COVID-19 Antigen Rapid Test Kits Worth 27.1 Billion KRW to Brazil
[Asia Economy Reporter Jang Hyowon] Humasis announced on the 22nd that it has signed a contract to supply COVID-19 antigen rapid test kits worth 27.1 billion KRW with 'FIOCRUZ - INSTITUTO DE TECNOLOGIA EM IMUNOBIOLOGICOS.'
Hot Picks Today
"It Has Finally Crossed Borders"... Greater Fear Due to Delayed Detection, No Treatment for Variant Ebola [Reading Science]
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
This amount corresponds to 59.23% of recent sales revenue. The contract period is until March 31, 2022, and the sales supply region is Brazil.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.